Перейти к содержимому

S01E16 - If I Were the CEO: Building a Pharma Factory That is hard to Replicate

15 Minutes of Pharma

0:00 / 0:00

S01E16 - If I Were the CEO: Building a Pharma Factory That is hard to Replicate

1 просмотр · 3 дня назад
15 Minutes of Pharma
18 подписчиков
1 просмотр · 3 дня назад
Could every function in a pharmaceutical manufacturing site be meeting its targets while the factory itself becomes less competitive? In Episode 16 of 15 Minutes of Pharma, Carlos Pereira da Cruz and Manuel Fernandes explore Capability Convergence and what makes a pharmaceutical manufacturing system difficult for competitors to replicate. A pharma site may have excellent technical expertise, strong Quality systems, modern equipment and experienced people. Its competitive strength, however, also depends on how those capabilities work together. In complex pharmaceutical manufacturing, the interactions between process science, Operations, Quality, Engineering, digital technology, energy economics and supply-chain resilience can create value that no single function could deliver independently. But integration alone is not enough. It must strengthen the industrial position and produce outcomes that customers value. In this episode, we discuss: Why strong functional performance does not always translate into a competitive factory. How complementary capabilities can reinforce one another, and why integration should be selective. Why CEOs and Boards should consider how individual CAPEX projects contribute to a coherent industrial position. How collective tacit knowledge develops through experience and cross-functional problem solving. Why constructive disagreement, early problem detection and learning from experience matter in a GMP environment. How a manufacturing organisation can become progressively more capable through a reinforcing cycle of learning and better execution. An important distinction runs through the conversation: valuable tacit knowledge must strengthen the organisation without creating dangerous dependence on individual experts. The same applies to culture. A strong can-do culture in pharma means having the confidence to surface problems, understand them and solve them together, while maintaining GMP discipline. Ultimately, the most difficult manufacturing capability to replicate may be the accumulated way in which an organisation has learned to work together. A great operating system also learns. And that leaves CEOs, Site Directors and CDMO leaders with a question worth considering: What is there in your manufacturing system that a competitor could not easily copy, and does the customer notice the difference? #Pharma #CDMO #PharmaManufacturing #IndustrialStrategy #CapabilityConvergence #OperationalExcellence #OrganisationalLearning #GMP #Leadership #ManufacturingStrategy #MEFPharmaSolutions